Thompson Rachel, Lyle Kate, Samuel Gabrielle, Holliday Jo, Starkey Fenella, Wallace Susan, Lucassen Anneke
University of Oxford, Oxford, UK.
King's College London, London, UK.
BMC Med Ethics. 2025 Apr 12;26(1):47. doi: 10.1186/s12910-025-01199-0.
This paper examines challenges associated with the governance of large-scale biobanks. As the collection and interrogation of population-scale data is increasingly positioned as a route to new understandings of health and disease, large-scale biobanks are becoming essential elements of research infrastructure. However, their longitudinal nature presents challenges for governance, particularly in relation to consent. Typically, participants agree to specific activities at recruitment, but evolving technologies make it difficult to anticipate future research applications at this time. Using a case study from UK Biobank, we demonstrate how trying to reconcile new research activities with old consent risks overlooking critical ethical issues -particularly how the proposed activity aligns with participants' understanding and expectation of biobank research.
We conducted focus groups with UK Biobank participants using individual and group exercises to explore their views on consent and different types of research on their samples and data.
Our findings show that participants locate responsibility for research decisions with the biobank, rather than seeking control through their consent. They perceive their consent not as a one-off agreement but as the `opening act' for a research relationship with the biobank that can be continued through communication.
Focussing on the ongoing research relationship -and the practices that sustain it- is more important than the specific wording on consent forms signed at recruitment. We argue this will be more effective in meeting participant expectation as well as supporting ethical research.
本文探讨了与大规模生物样本库管理相关的挑战。随着对人群规模数据的收集和问询越来越被视为获得对健康与疾病新认识的途径,大规模生物样本库正成为研究基础设施的重要组成部分。然而,其纵向性质给管理带来了挑战,尤其是在知情同意方面。通常,参与者在招募时同意特定的活动,但不断发展的技术使得此时难以预见未来的研究应用。通过英国生物样本库的一个案例研究,我们展示了试图使新的研究活动与旧的知情同意相协调如何可能忽视关键的伦理问题——特别是拟议的活动如何符合参与者对生物样本库研究的理解和期望。
我们与英国生物样本库的参与者进行了焦点小组讨论,采用个人和小组活动来探讨他们对知情同意以及对其样本和数据进行不同类型研究的看法。
我们的研究结果表明,参与者将研究决策的责任归于生物样本库,而非试图通过他们的知情同意来进行控制。他们将自己的知情同意视为与生物样本库研究关系的“开场之举”,而非一次性协议,这种关系可以通过沟通得以延续。
关注持续的研究关系——以及维系这种关系的实践——比招募时签署的知情同意书上的具体措辞更为重要。我们认为,这在满足参与者期望以及支持伦理研究方面将更为有效。